TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: LEO Sachs To Receive 1983 Bristol-Myers Award; 50 Percent Current Rate Achievable Now: Tylor April 1, 1983
TCL Archive In Brief: Glick, Armitage Lead ASCO; NCAB Approves Resolution Calling For Higher NIH Budget June 2, 1995
